We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SEC Official Urges Greater Drugmaker Disclosure of Dealings with FDA
SEC Official Urges Greater Drugmaker Disclosure of Dealings with FDA
The SEC is urging drugmakers to include details of FDA correspondence about products in 8-K disclosure filings, or to post portions of them on their websites, to make sure shareholder communications are accurate.